article thumbnail

Prescription drug marketing misconceptions

World of DTC Marketing

Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. The disconnect between consumers and prescription drug marketing has grown quite a bit. Prescription drug marketers are jumping through hoops to convince management that drug advertising is necessary but data is fading.

article thumbnail

What Will Rite Aid Need to Do to Recover from Bankruptcy?

MedCity News

Rite Aid filed for Chapter 11 bankruptcy protection on Sunday amid decreasing sales, billions of dollars in debt and more than a thousand lawsuits claiming the chain filled illegal prescriptions for opioids.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much. DTC ads raise awareness around health conditions.

Marketing 285
article thumbnail

With Wegovy supplies back on tap, Novo Nordisk's obesity med doubles US prescriptions from start of year

Fierce Pharma

With supplies of its star obesity med Wegovy now largely unfettered, Novo Nordisk is dialing up its sales expectations for the remainder of the year—and teasing the potential for net price declines | With supplies of its star obesity med Wegovy now largely unfettered, Novo Nordisk is dialing up its sales expectations for the remainder of the year—and (..)

article thumbnail

The Path for Prescription Drug Sales

Pharmaceutical Commerce

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.

article thumbnail

Biogen boosts profit guidance despite modest quarter for Leqembi and multiple sclerosis downturn

Fierce Pharma

Leqembi sales grew 33% over the prior quarter to $39 million, falling short of consensus estimates. But behind the scenes, there was a 40% uptick in the number of new prescribers writing prescriptions for Leqembi in the third quarter versus Q2, Alicia Alaimo, Biogen’s president and head of North America, said Wednesday.

article thumbnail

Biden proposes subsidizing drug middlemen for insulin

World of DTC Marketing

Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated price for a 30-day prescription. This could cost taxpayers billions over the year. Los Angeles Times.

Insurance 240